|
|
2 Goodyear
Irvine
CA
92618
United States
(949) 595-8710
|
|
PUBLIC
|
IsoTis (NASDAQ: ISOT) manufactures, markets and sells a range of innovative bone graft substitutes and other related medical devices that are used to enhance the repair and regeneration of bone in spinal and trauma surgery, total joint replacements and dental applications. The orthobiology segment of the orthopedics market on which IsoTis focuses is valued at approximately $1 billion today, and is estimated to grow at a compounded annual growth rate of 20% to reach the $2 billion mark in 2010. IsoTis’ main commercial operations are based in Irvine, California, and its international sales headquarters are based in Lausanne, Switzerland. IsoTis reported revenues of $40.7 million in 2006, a 27% increase over 2005.
|
|
http://www.isotis.com
|
|
|
|
|
|
|
|
|
|
DynaGraft®II Product Literature
DynaGraft® II is a unique bone graft substitute composed of demineralized bone matrix (DBM) in a reverse phase medium. Used either alone or as a bone graft extender, it helps promote successful surgical outcomes by providing:
Proven osteoinductivity – Each lot of DBM is tested in a quantitative in vitro assay for its ability to stimulate new bone formation.
read more...
|
|
OrthoBlast® II Product Literature
Combining osteoinductive and osteoconductive elements in a proprietary, reverse phase medium, OrthoBlast® II is a powerful choice for bone grafting. Available in both putty and paste, they contain demineralized bone matrix (DBM) to stimulate new bone growth, and cancellous bone to support bone formation – plus a unique, temperature-responsive medium that facilitates both handling and graft containment.
read more...
|
|
|
|
|
|
|